| Trade Names: | |
| Synonyms: | |
| Status: | Approved (1991) |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | DX1U2629QE |
Structure
| InChI Key | ACTRVOBWPAIOHC-XIXRPRMCSA-N |
|---|---|
| Smile | |
| InChI |
|
Physicochemical Descriptors
| Property Name | Value |
|---|---|
| Molecular Formula | C4H6O4S2 |
| Molecular Weight | 182.22 |
| AlogP | -0.25 |
| Hydrogen Bond Acceptor | 4.0 |
| Hydrogen Bond Donor | 4.0 |
| Number of Rotational Bond | 3.0 |
| Polar Surface Area | 74.6 |
| Molecular species | ACID |
| Aromatic Rings | 0.0 |
| Heavy Atoms | 10.0 |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| CHELATING AGENT | Lead chelating agent | FDA |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Unclassified protein
|
- | - | - | - | 69-100 |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Autistic Disorder | 2 | D001321 | ClinicalTrials |
| Asperger Syndrome | 2 | D020817 | ClinicalTrials |
| Myelodysplastic Syndromes | 1 | D009190 | ClinicalTrials |
| Blast Crisis | 1 | D001752 | ClinicalTrials |
| Hepatolenticular Degeneration | 0 | D006527 | ClinicalTrials |
Related Entries
MCS
Adverse Reactions
System Organ Classification (SOC)
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 304-55-2 |
| ChEBI | 63623 |
| ChEMBL | CHEMBL1201073 |
| DrugBank | DB00566 |
| DrugCentral | 2486 |
| EPA CompTox | DTXSID1023601 |
| FDA SRS | DX1U2629QE |
| PubChem | 2724354 |
| SureChEMBL | SCHEMBL14941 |
| ZINC | ZINC000003831475 |
CONTENTS